Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PDT, BFA, PSF, SBS

Rapid MedLab Extends Molecular COVID-19 Testing

ST. LOUIS, Feb. 24, 2021 /PRNewswire/ -- Rapid MedLab announced today its corporate testing services for businesses in St. Louis. With the introduction of corporate testing, Rapid MedLab will provide molecular COVID-19 testing and diagnostics for its corporate partners to help them alleviate the stressors as they welcome employees back to work. Rapid MedLab will test employees and staff at any time and frequency as needed by corporate partners. 

The benefits of Rapid MedLab's corporate testing includes: 

To expand testing efforts, Rapid MedLab announced today the acceptance of insurance.  Rapid MedLab's Des Peres location (2155 Barrett Station Rd, Des Peres, MO 63131) will offer COVID-19 tests to individuals and bill insurance on their behalf.  

"Over the course of the past few months, we have seen a surplus of our patients desire to have their insurance company pay for their COVID-19 test," says David Cerven, CEO at Rapid MedLab. "We hope that this new service will allow Missouri residents to get tested and immediately get back to work, school, social gatherings, or travel." 

About Rapid MedLab 
Breaking the industry mold, Rapid MedLab is revolutionizing the relationship between the patient, the testing experience, and diagnostics. Rapid MedLab provides highly reliable, rapid, infectious disease testing for patients and corporate clients through a contactless, in-and-out patient experience. Rapid MedLab currently provides molecular COVID-19 testing and diagnostics. No appointment needed, Rapid MedLab provides curbside check-ins. With no-wait, testing is administered within 5 minutes and results are provided within 15 minutes. For more information, visit www.RapidMedLab.com 



SOURCE Rapid MedLab

These press releases may also interest you

at 08:52
Hensler Surgical Technologies today announced its newly obtained CE mark for the Hensler Bone Presstm (HBP). "Harvesting drilled...

at 08:50
Image-guided surgery offers surgeons greater control of the procedure and real-time feedback, thus providing better outcomes for patients. Accuracy in surgical procedures is critical for serious or life-threatening conditions, such as cancer, and...

at 08:50
Following the lack of action by the FDA to expedite approval of AMX0035, an experimental treatment for ALS, The ALS Association today called on the agency to follow its own guidance and move with the urgency of its Canadian and European Union...

at 08:50
On Tuesday April 13th, Orlando-based Quality One Wireless (Q1, LLC) became one of the first companies in the state of Florida to bring free COVID vaccines on-site for both employees and families. ...

at 08:47
Lore IO, Inc., providers of an AI-powered common data model that enables faster data onboarding and unified data views, today announced the immediate availability of its freemium offering of Lore IO Pre-Commercial Launch Analytics. The offering helps...

at 08:45
Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced today that the following clinical trials have been initiated to support a label expansion of its FDA-approved innovative...

News published on 24 february 2021 at 07:35 and distributed by: